LEN.DELEN.DEXETRA
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank74
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P74
Within normal range
vs 2Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 5.80% |
| Q2 2025 | -5.48% |
| Q1 2025 | -2.09% |
| Q4 2024 | 11.28% |
| Q3 2024 | -14.10% |
| Q2 2024 | 8.33% |
| Q1 2024 | -86.17% |
| Q4 2023 | 677.25% |
| Q3 2023 | 8.06% |
| Q2 2023 | 51.22% |
| Q1 2023 | -56.91% |
| Q4 2022 | 94.16% |
| Q3 2022 | -30.00% |
| Q2 2022 | -10.26% |
| Q1 2022 | 18.31% |
| Q4 2021 | 8.08% |
| Q3 2021 | 3.39% |
| Q2 2021 | 9.26% |
| Q1 2021 | -76.74% |
| Q4 2020 | 729.21% |
| Q3 2020 | -28.21% |
| Q2 2020 | -20.41% |
| Q1 2020 | -90.80% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | -100.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |
| Q4 2015 | 0.00% |